Date/Time
Date(s) - 01/25/2023
5:00 pm - 6:30 pm
Location
Fitts Auditorium, Penn Law
Categories No Categories
Join the Master in Law Program for a panel discussion on the legal disputes surrounding patent ownership of CRISPR technology, a groundbreaking tool that enables gene editing to correct genetic defects, treat and prevent disease, and improve crops.
Using the example of a current vaccine that was developed with CRISPR technology, our panel of experts will explain the patent and licensing process and the ongoing court battles over ownership of CRISPR patents.
A reception will follow the panel discussion and Q&A.
REGISTER: https://pennlaw.cvent.com/d/slq9r6
Panelists:
– Kiran Musunuru, MD ML’19, Penn Geneticist, Cardiologist, Faculty, and
Co-Founder and Senior Scientific Advisor of Verve Therapeutics
– Hon. Leonard P. Stark, Judge, U.S. Court of Appeals for the Federal Circuit
– R. Polk Wagner, Michael A. Fitts Professor of Law, Author, and Intellectual Property Expert